MSD’s Keytruda closer to classical Hodgkin Lymphoma nod

27th March 2017 Uncategorised 0

MSD’s anti-PD-1 therapy Keytruda has taken a giant leap towards being approved in Europe for the treatment of classical Hodgkin Lymphoma (cHL).

More: MSD’s Keytruda closer to classical Hodgkin Lymphoma nod
Source: News